Literature DB >> 21518975

Pre-B cell colony-enhancing factor (PBEF/Nampt/visfatin) primes neutrophils for augmented respiratory burst activity through partial assembly of the NADPH oxidase.

Zeenat Malam1, Jean Parodo, Faiza Waheed, Katalin Szaszi, Andras Kapus, John C Marshall.   

Abstract

Pre-B cell colony-enhancing factor ([PBEF] also known as Nampt/visfatin) is a pleiotropic 52-kDa cytokine-like molecule whose activity has been implicated in multiple inflammatory disease states. PBEF promotes polymorphonuclear neutrophil (PMN) proinflammatory function by inhibiting constitutive PMN apoptosis. We investigated whether PBEF activates or primes for PMN respiratory burst. We found that although PBEF did not activate respiratory burst on its own, it primed for increased reactive oxygen species generation through the NADPH oxidase. PBEF promoted membrane translocation of cytosolic NADPH oxidase subunits p40 and p47, but not p67, induced p40 phosphorylation on Thr(154), and activated the small GTPase Rac. Priming, translocation, and phosphorylation were dependent on activation of p38 and ERK MAPKs, but not of PI3K. Priming by PBEF occurred independent of its NAD-generating capacity because neither nicotinamide mononucleotide or NAD could recapitulate the effects, and a specific inhibitor of PBEF, APO-866, could not inhibit priming. Taken together, these results demonstrate that PBEF can prime for PMN respiratory burst activity by promoting p40 and p47 translocation to the membrane, and this occurs in a MAPK-dependent fashion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518975     DOI: 10.4049/jimmunol.1003706

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Increased visfatin expression is associated with nuclear factor-kappa B and phosphatidylinositol 3-kinase in periodontal inflammation.

Authors:  Erkan Özcan; N Işıl Saygun; Rahşan Ilıkçı; Yıldırım Karslıoğlu; Uğur Muşabak; Sait Yeşillik
Journal:  Clin Oral Investig       Date:  2016-06-09       Impact factor: 3.573

2.  Visfatin impairs endothelium-dependent relaxation in rat and human mesenteric microvessels through nicotinamide phosphoribosyltransferase activity.

Authors:  Susana Vallejo; Tania Romacho; Javier Angulo; Laura A Villalobos; Elena Cercas; Alejandra Leivas; Elena Bermejo; Raffaele Carraro; Carlos F Sánchez-Ferrer; Concepción Peiró
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

3.  Association between serum visfatin and carotid atherosclerosis in diabetic and non-diabetic patients on maintenance hemodialysis.

Authors:  Samia Hassan El-Shishtawy; Osama Mosbah; Nevine Sherif; Amna Metwaly; Amr Hanafy; Laila Kamel
Journal:  Electron Physician       Date:  2016-02-25

4.  Metabolic and molecular insights into an essential role of nicotinamide phosphoribosyltransferase.

Authors:  Li Q Zhang; Leon Van Haandel; Min Xiong; Peixin Huang; Daniel P Heruth; Charlie Bi; Roger Gaedigk; Xun Jiang; Ding-You Li; Gerald Wyckoff; Dmitry N Grigoryev; Li Gao; Linheng Li; Min Wu; J Steven Leeder; Shui Qing Ye
Journal:  Cell Death Dis       Date:  2017-03-23       Impact factor: 8.469

5.  MC-PPEA as a new and more potent inhibitor of CLP-induced sepsis and pulmonary inflammation than FK866.

Authors:  Peixin Huang; Mark W Lee; Keivan Sadrerafi; Daniel P Heruth; Li Q Zhang; Dev Maulik; Shui Qing Ye
Journal:  Drug Des Devel Ther       Date:  2017-03-03       Impact factor: 4.162

6.  Nicotinamide phosphoribosyltransferase may be involved in age-related brain diseases.

Authors:  Li-Ying Liu; Feng Wang; Xia-Yan Zhang; Peng Huang; Yun-Bi Lu; Er-Qing Wei; Wei-Ping Zhang
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

7.  NAMPT-mediated salvage synthesis of NAD+ controls morphofunctional changes of macrophages.

Authors:  Gerda Venter; Frank T J J Oerlemans; Marieke Willemse; Mietske Wijers; Jack A M Fransen; Bé Wieringa
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.